Abstract. The control of some childhood diseases has proved to be difficult even in countries that maintain high vaccination coverage. This may be due to the use of imperfect vaccines, and there has been much discussion on the different modes by which vaccines might fail. To understand the epidemiological implications of some of these different modes, we performed a systematic analysis of a model based on the standard susceptible-infectious-recovered equations with a vaccinated component that permits vaccine failure in degree ("leakiness"), take ("all-or-nothingness"), and duration (waning of vaccine-derived immunity). The model was first considered as a system of ordinary differential equations and then extended to a system of partial differential equations to accommodate age structure. We derived analytic expressions for the steady states of the system and the final age distributions in the case of homogenous contact rates. The stability of these equilibria are determined by a threshold parameter Rp, a function of the vaccine failure parameters and the coverage p. The value of p for which Rp = 1 yields the critical vaccination ratio, a measure of herd immunity. Using this concept, we can compare vaccines that confer the same level of herd immunity to the population but may fail at the individual level in different ways. For any fixed Rp > 1, the leaky model results in the highest prevalence of infection, while the all-or-nothing and waning models have the same steady state prevalence. The actual composition of a vaccine cannot be determined on the basis of steady state levels alone, but the distinctions can be made by looking at transient dynamics (such as after the onset of vaccination), the mean age of infection, the age distributions at steady state of the infected class, and the effect of age-specific contact rates.
constant and age-specific contact rates, changes with increasing vaccination coverage. We summarize our results and give some concluding remarks in section 5.
2. An ODE model of an imperfect vaccine. The model is illustrated in Figure 1 . Let V (t) be the fraction of the total population that is in the vaccinated state. By this state we mean the proportion of the population that was vaccinated and enjoys some protection from the vaccine. (The vaccine did not fail in take in these individuals, and their immunity has not waned yet.) Let S(t) be the fraction that is in the susceptible class. This includes the vaccinated individuals for whom the vaccine had no effect from the beginning, as well as those whose immunity has waned by time t. The remaining compartments are I(t) and R(t), fractions of the total population in the infectious and recovered states, respectively. To be consistent with these definitions, we require that V (t) + S(t) + I(t) + R(t) = 1 for all t 0.
Suppose that the model population has equal birth and death rates of μ. Most of the connections in Figure 1 between S, I, and R are from the standard KermackMcKendrick SIR model [9, 18] . (The symbols used for the different parameters are Downloaded 12/12/14 to 71.205.60.120. Redistribution subject to SIAM license or copyright; see http://www.siam.org/journals/ojsa.php given in Table 1 .) We expand upon the SIR model by adding the vaccinated class V with connections to S and I. For all t 0, a constant fraction p of the newborns are assumed to be vaccinated. Of this fraction, a proportion ε A ∈ [0, 1) (the all-ornothing parameter) exhibit failure in take and go directly instead to the susceptible class. The individuals in the vaccinated class experience a reduction by ε L ∈ [0, 1) (the leakiness parameter) in the probability of getting infected. Vaccine protection is also assumed to wane at a rate of α = μεW 1−εW . This parametrization was chosen so that the parameter ε W is the probability that the vaccine protection of individuals in the V class wanes within a lifetime given that they do not get infected first.
(2.1) ε W = α α + μ = rate at which vaccine protection wanes rate at which individuals leave the V class if ε L = 0 .
The choice of ε W also results in this parameter having the same range of ε W ∈ [0, 1) and the same weight in determining the stability of the disease-free equilibrium as both ε L and ε A . This will be shown later on when we define the basic reproduction number of this system R p . Going back to the three vaccines we considered in section 1, vaccine 1 is given by (ε L , ε A , ε W ) = (ε, 0, 0), vaccine 2 by (ε L , ε A , ε W ) = (0, ε, 0), and vaccine 3 by (ε L , ε A , ε W ) = (0, 0, ε). The waning rate of vaccine 3 is α = με 1−ε , which translates to a waning rate that is exponentially distributed with mean equal to 1−ε ε times the expected host lifetime. Definition 2.1 presents the full set of model equations for a general imperfect vaccine that can take on any value of (ε L , ε A , ε W ) ∈ [0, 1)
3 .
Definition 2.1.
The imperfect vaccine ODE model is given by the following system of ODEs,
for t 0, where α = μεW 1−εW and the initial conditions satisfy (2.3)
We call (ε L , ε A , ε W ) the vaccine failure parameters. In the case when ε L > 0 and ε A = ε W = 0, we call this the leaky ODE model. In the case when ε A > 0 and ε L = ε W = 0, we call this the all-or-nothing ODE model. In the case when ε W > 0 and ε L = ε A = 0, we call this the waning ODE model. We also define ϕ, a measure of vaccine impact by
and the basic reproduction number for this model by 
The definition of the vaccine impact parameter ϕ is the same as the ϕ = εψμ μ+α in McLean and Blower [14] if their ε is replaced by 1 − ε L , ψ by 1 − ε A and α by μεW 1−εW . It is also consistent with the vaccine efficacy (VE) defined by Farrington [4] for more general types of leaky and all-or-nothing vaccines where VE = PE p and PE = 1 − Rp R0 is the projected effectiveness of the vaccine. In our example, vaccines 1-3 all have ϕ = 1 − ε, consistent with the values for efficacy discussed in section 1. The parameters of the model and their default values used in simulations and sample plots are summarized in Table 1 . The default value of the recovery and transmission rates were chosen to have the infectious period and basic reproduction number of pertussis. The special cases of the imperfect vaccine model that we consider in our simulations are summarized in Table 2 .
3. Dynamics and properties of the ODE model. In this section we examine the properties of the imperfect vaccine ODE model (Definition 2.1) with a focus on its equilibria. In Proposition 3.1, the well-posedness of the model and the invariance of solutions in the positive orthant are established. We also derive expressions for the disease-free and endemic equilibria and establish the threshold property of the basic reproduction number R p in determining the existence and stability of these steady states. The critical vaccination ratio p c is defined in Definition 3.1 to be the minimum vaccination probability required to drive the disease to extinction, if this is possible. We also state Propositions 3.2-3.3, which present results on the equality of the steady states for different combinations of the vaccine failure parameters (ε L , ε A , ε W ) and prove that for a fixed value of ϕ, the purely leaky model provides an upper bound on the steady state level of infection. At the end of the section we show plots of the steady states of the special cases as different parameters are varied ( Figure 2) . We also present some interesting transient dynamics displayed by the leaky and waning vaccines models at the onset of a vaccination program (Figure 3) . Proposition 3.1. The vaccine failure model in Definition 2.1 has the following properties:
1 
. The system of equations is well-posed and invariant in the set
and if ε L = 0, then instead 
Thus it is clear from (3.2) that R p = 1 is the point at which I * changes sign. The basic reproduction number R p as a function of vaccination rate p of the system (2.2) was derived using the next-generation matrix method. (Refer to [18] for a discussion of this method.) This guarantees the local asymptotic stability of the disease-free equilibrium in the case when R p < 1 and instability when R p > 1. Global asymptotic stability in the case when R 0 < 1 can be proved using a Lyapunov function
Since S + ε L V S + V 1, the derivative is negative-definite in the case when R 0 < 1. For the proof of local asymptotic stability of the endemic equilibrium for R p > 1, we prove that the dominant eigenvalue of the Jacobian matrix evaluated at this steady state lies on the left half of the complex plane (see Proposition A.4).
From the threshold property of R p we may be able to derive the critical proportion of the population that needs to be vaccinated in order to achieve eradication of the disease. This critical proportion may not exist if the vaccine impact parameter ϕ is too small. 
if this expression is less than or equal to one. By Proposition 3.1, if p > p c , then R p < 1 and the disease-free equilibrium is locally asymptotically stable. For the same disease, the critical vaccination ratio depends only on ϕ and hence is the same for vaccines 1-3 in our example from section 1.
In Proposition 3.2, we derive conditions on the vaccine failure parameters that lead to the same steady state values. We also prove that for a fixed value of ϕ, the leaky model provides an upper bound on the infection level in Proposition 3.3. Applied to our example vaccines, these results show that the disease-free and endemic steady states of vaccines 2 and 3 are identical while vaccine 1 results in a larger infection at the endemic steady state.
Proposition 3.2. Suppose that P (1) is the set of parameter values with vac-
W ) and P (2) is another set with
W ). All other parameters are the same in P (1) and P (2) . Then the following hold:
1.
The component values at the disease-free equilibrium are the same for either parameter set independent of the value of ε
L as long as
W .
The component values at the endemic equilibrium are the same for either parameter set as long as ε
(1)
Proof. These statements follow from the expressions derived in Proposition 3.1. Proof. Suppose that ϕ is fixed and set
2) in Proposition 3.1, the endemic steady-state infected class can be written as 
where
When a b, this is clearly true, so consider the case when a < b.
The last inequality is clearly true when R p > 1, and it follows that the value of the endemic steady state increases with x. Thus the maximum occurs when ε L = 1 − ϕ and ε A = ε W = 0.
In the bifurcation diagrams and sample simulations that we present in this paper, we use vaccines 1, 2, and 3 as examples for the leaky, all-or-nothing (denoted by AON) and waning models, respectively. When ε is not being varied, we set ε = 0.2 (refer to Table 2 ). In Figures 2(a) -(c) we plot the infected class steady state I * against different model parameters. When any parameter is fixed and its value is not indicated in the figure, it is set to the default value in Table 1 . In Figure 2 (d) we plot the imaginary part of the eigenvalues of the Jacobian matrix against the parameter β and show that the value is slightly smaller for the leaky model. This indicates that the leaky model has a slightly longer period for small oscillations, at least for the parameter ranges that we have chosen. Although not shown, this statement is supported by simulations of stochastic versions of the models and deriving the dominant frequencies.
It is clear from Proposition 3.2 and Figure 2 that we cannot uniquely identify the parameters of vaccine failure using steady state data alone. In particular, we cannot distinguish between the all-or-nothing and waning model by just looking at the equilibrium values of the components. Furthermore, in practice we may only have data available on I * or R * , and it would be difficult to determine how the remaining population splits up between S * (which includes vaccinated individuals whose immunity has waned) and V * . Since the vaccine failure parameters may be indeterminable from steady state data, we turn our attention to transient dynamics. In Figure 3 numerical simulations were used to compare the behavior of solutions after the start of vaccination programs employing the three special cases of vaccines. Here we finally observe a clear distinction between the dynamics of an all-or-nothing model and a waning model with the same value of ϕ. Simulations such as the one shown indicate that the latter displays an initial drop to low disease prevalence after the start of vaccination and then recovers to have the same steady state value as the all-or-nothing model. This temporary period of low disease prevalence is called the honeymoon period. For the set of parameter values that we chose, the all-or-nothing model does not appear to display a significant honeymoon period while the leaky model does. These are important considerations for vaccination programs. Furthermore, these observations present an alternative explanation for the observed "resurgence" of some diseases like pertussis in highly vaccinated regions. The documented rise in incidence may just be signaling the end of the honeymoon period, and the observed disease outbreaks may be transient oscillations such as those we see in Figure 3 (a).
Simulations using different combinations of (ε L , ε A , ε W ) for which ϕ = 0.8 appear to display behavior that is intermediate between the extremes of the special cases that are being combined. In Figure 3 , we include a simulation of the combined model with
, which displays transient behavior that is bounded above by the leaky model and below by the waning model. One can also check that a simulation with (
shows intermediate behavior between the leaky and all-or-nothing models.
4. An age-structured PDE model of an imperfect vaccine. In this section we introduce age structure to the model using an extension of the McKendrick-von Förster population model [13, 19] . This extension is standard and is also used by Inaba [8] and Thieme [17] . A formal definition of the imperfect vaccine PDE model is given in Definition 4. with an assumption that the total population dynamics is not affected by the disease. To keep the focus on the different modes of vaccine failure we also assume that the total population is already at its equilibrium age distribution. The existence of a classical solution to the system (in the sense of an abstract Cauchy problem) as well as the consistency of the above assumptions with the model statement is established in Proposition 4.1. In the special case where homogenous transmission rates are used, it is shown in Remark 4.1 that integrating the PDE system over all ages lead to the original ODE system in Definition 2.1. Expressions for the steady states age distributions are also derived and presented in Proposition 4.2. We end this section with plots showing the different steady state mean ages of infection and age distributions of the special cases of the model as parameters are varied.
an essentially bounded function). The imperfect vaccine PDE model is given by the following system of PDEs:
For t 0, we require the boundary conditions 
where ψ v , ψ s , ψ i , and ψ r ∈ L 1 ([0, ∞), R + ) are absolutely continuous functions. We assume that the total population is already in equilibrium at t = 0 so the initial conditions are required to satisfy
as well as,
The function b(t, a, x) incorporates the contact and transmission rate between individuals of ages a and x at time t. The initial age distribution given in (4.4) guarantees that the total population is already at a steady state age distribution but each component is not necessarily at equilibrium. This is discussed further in Proposition 4.1.
Proposition 4.1. There exists a unique classical solution to the system (4.1) which is defined for t 0. Furthermore, for t 0,
v(t, a) + s(t, a) + i(t, a) + r(t, a)
= μe −μa , ∞ 0
[v(t, a) + s(t, a) + i(t, a) + r(t, a)]da = 1.
Proof. Local existence and uniqueness follows from setting up the PDE problem (4.1) as an abstract semilinear Cauchy problem in the Banach space L 1 ([0, ∞), R 4 + ) as in [8] . The nonnegativity of the solution follows from applying the formula for integration along characteristics for v and s, and then writing the equation for i as an abstract Cauchy problem (see [8] ).
Let n(t, a) = v(t, a) + s(t, a) + i(t, a) + r(t, a) and consider the system ∂n(t, a) ∂t
which is derived from (4.1)-(4.3). Using the method of characteristics, the solution is
t a.
Initial conditions state that n(0, a − t) = μe −μ(a−t) so n(t, a) = μe −μa follows. Also, 
[v(t, a) + s(t, a) + i(t, a) + r(t, a)]da
The global existence and uniqueness of the solution follow from the positivity and boundedness of the solutions for all t 0. It is clear that for a constant contact rate b(t, a, x) = β, integrating the PDE system (4.1) over all ages yields the original ODE system (2.2).
Remark 4. In the next proposition we derive expressions for the disease-free and endemic steady states of the model when b(t, a, x) = β. We also state the threshold property of R p in determining the existence and stability of the steady states. This last result simply follows from the previous proposition and the results in the previous section.
Proposition 4.2. Let b(t, a, x) = β > 0. The disease-free equilibrium of the PDE model is given by
(4.6) v 0 (a) = μp(1 − ε A )e −μa , s 0 (a) = μ (1 − (1 − ε A )p) e −μa , i 0 (a) = 0, r 0 (a) = 0. Let β(t, a, x) = β, a constant. If ε L = α = 0 (
the all-or-nothing case), then endemic steady state distributions are given by
If ε L and α are not both zero, the endemic steady state distributions are given by Proof. The steady states are found by setting all derivatives with respect to time in (4.1) equal to zero. To find the disease-free equilibrium we set i(t, a) = 0. This leads to an ODE system that has solutions given by (4.6), and this exists for all allowable parameter values.
In the homogenous case, the steady state expression for λ i (t, a) is independent of t and a. To solve for the endemic equilibrium, the expressions (4.7) and (4.8) can be derived by performing the integration with a fixed λ i (t, a) = λ * . With the endemic steady state expression i * (a) known, it is possible to solve for λ * . The expression for λ * for the all-or-nothing case is easy to derive. When ε L and α are not both zero, simplifying λ * = β ∞ 0 i * (x) dx leads to (4.9). Solving for a nonzero λ * and substituting λ * = βz yields the solution z = I * as in (3.2) in Proposition 3.1. From this earlier result, the existence, uniqueness, and positivity of the endemic equilibrium is guaranteed when R p > 1.
The proof of local stability is straightforward. If R p < 1, Proposition 3.1 states that if the initial conditions are close enough to the disease-free equilibrium, I(t) = ∞ 0 i(t, a)da → 0 and λ i (t, a, x) = βI(t) → 0 as t → ∞. Thus, as t → ∞, (4.1) approach a linear system that can be solved by integration along the characteristics starting from a = 0.
From this derive that (v(t, a), s(t, a), i(t, a), r(t, a))
→ (v 0 (a), s 0 (a), i 0 (a), r 0 (a)) as t → ∞. Similarly, if R p > 1
and we start close to the endemic equilibrium, λ i (t, a, x) → λ * and we can show that (v(t, a), s(t, a), i(t, a), r(t, a))
In all cases where ε L = 0 (which is true for any combination of all-ornothing and waning model), we have the steady state force of infection λ * = μ(R p −1). To determine the mean age of infection in the case when b(t, a, x) = β, we divide the expression
by I * , which is given in (3.2). For fixed ϕ = 1− ε, the leaky and all-or-nothing models have the same mean age of infection at λ * = 0 (corresponding to R p = 1), and the gap between that and the mean age of the waning model is given by pε (μ+ε)(μ(1−p)+ε) . In Figure 4 we plot λ * and the mean age of infection as a function of β when the transmission rate is fixed at b(t, a, x) = β. These are shown for the standard three special cases as well as for a combined model where
The values could be analytically calculated using the steady state expressions in Proposition 4.2. The mean age of infection at steady state plots show that the lowest mean age of infection occurs in vaccine 2, the all-or-hing example. This is followed by vaccine 1, the leaky example, and then the combined model. Unsurprisingly, vaccine 3, the purely waning model, has the highest mean age of infection. This plot shows another observable distinction between vaccines 2 and 3 which could not be differentiated using the steady state data without age structure.
In Figure 5 we plot the age distribution of the infected class (divided into school age classes) for the three special cases as a function of the infant vaccination probability p. These plots are shown for both homogenous b(t, a, x) = β and age-specific b(t, a, x) based on the contact structure matrix presented in Mossong et al. [15] . This matrix features assortative mixing with school children and young adults more likely to contact people of similar age. We normalized the contact matrix so that it has a mean value that is the same as β. In the case with homogenous contact rates the distributions can be analytically calculated from the expressions in Proposition 4.2. In the case with age-specific contacts the steady states were numerically evaluated. It is clear from Proposition 4.2 that different vaccine failure parameters will lead to different distributions even with the same ϕ. Interestingly, the distributions of the age classes respond in different manners as p is increased. In particular we note that in the case with age-structured contacts, as p is increased the proportion of the infected class aged 1-7 appear to grow for the leaky case, remain roughly the same for the all-or-nothing case, and decrease for the waning case.
Summary and conclusions.
Clinical trials focus on the benefits that vaccines provide at the individual level. In these controlled experiments the effects on herd immunity cannot be measured directly. Using models, we can extrapolate from individual to population-level effects and determine the epidemiological ramifications of using different types of imperfect vaccines. We considered a mathematical model of an imperfect vaccine that may exhibit failures in degree (leakiness), take (all-ornothingness) and duration (waning of vaccine-derived immunity). Vaccines 1, 2, and 3, described in section 1, are special cases corresponding to the leaky, all-or-nothing, and waning models, respectively. The ODE equations, given in Definition 2.1, were derived in section 2 with the underlying assumption that the disease without vaccination follows SIR dynamics. In the same section we defined a vaccine impact parameter ϕ consistent with other definitions of vaccine effectiveness in [4] and [14] . Based on this, we showed how vaccines 1-3 are comparable to each other in terms of vaccine individual-level efficacy.
In section 3 we examined the dynamics of the ODE model. In Proposition 3.1 the disease-free and endemic steady states of the model were derived. The stability of these steady states depend on the value of the basic reproduction number R p , which depends on ϕ. When the endemic equilibrium is stable, we showed in Proposition 3.2 that the vaccine parameters cannot be uniquely determined based on steady state [1, 7) , [7, 11) , [11, 20) , and [20, ∞) years at the endemic steady state of (4.1) for homogenous transmission β = 400 and age-specific transmission based on the contact structure described in [15] . For a fixed value of ϕ, we showed in Proposition 3.3 that the highest level of infection is obtained if all of the vaccine failure stems from leakiness. There have been other studies that point toward this result. White et al. [20] and Smith, Rodrigues, and Fine [16] compared the efficacy of leaky and all-or-nothing vaccines and concluded that a leaky vaccine performs worse than an all-or-nothing vaccine. However, in these papers the comparisons were done assuming a constant force of infection. In Proposition 3.3 we compared the vaccine models in the case when the force of infection actually depends on the choice of vaccine.
At the end of section 3 we presented graphs of the steady states of the special cases of the vaccines from section 1. The all-or-nothing and waning models were shown to have the same steady states (consistent with Proposition 3.2), while the leaky model had a higher level of infection at endemic state (consistent with Proposition 3.3). The leaky model was also observed to have a longer period for small oscillations compared to the other two.
Sample simulations of the onset of a vaccination program were also included to show how transient dynamics can highlight the difference between the models even when they have matching steady state data. Leaky and waning models appear to both exhibit a "honeymoon period" after the onset of vaccination which the all-or-nothing model does not display. Although these are transient dynamics, they can have important implications for vaccination programs. Moreover, these provide an alternative explanation for the observed "resurgence" of some diseases like pertussis in regions that have maintained high vaccination coverage. The rise in incidence may just be due to the end of the honeymoon period, and the occurrence of large disease outbreaks may be transient oscillations during a slow transition to a vaccine-era steady state.
In section 4 we extended the ODE model into an age-structured PDE model given in Definition 4.1. The well-posedness of the equations and the consistency of the model assumptions were established in Proposition 4.1. When the transmission rate is assumed to be constant, integrating the PDE system with respect to age leads back to the original ODE model (Remark 4.1). In this case, the disease-free and endemic steady states can be analytically derived and the stability of this equilibrium is also determined by R p . This is presented in Proposition 4.2, where the steady state age distributions of the model are also given. The formula shows that the distributions are distinct for different sets of values of the vaccine failure parameters. Other steady state measures can also be derived from these equations that provide useful information about the dynamics and allow us to distinguish between the different vaccines. One such measure is the mean age at infection, which in our example is highest for the waning model, is followed by the leaky model, and is lowest for the all-or-nothing model.
The age distributions of the infected class under the assumption of age-specific transmission were also examined numerically. Figure 5 shows how the proportion of the different age groups for the different vaccines may respond differently to changes in vaccine coverage. For our choice of parameter values, the contrast was particularly pronounced for the group between the ages of 1-7.
Our results suggest that there is enough difference in the epidemiological signatures of imperfect vaccines to determine the parameters of the vaccine used in a region where the disease is endemic despite significant vaccination coverage. It would be interesting to use the available incidence time series data on a disease like pertussis to see if an imperfect vaccine model can adequately explain the honeymoon period and resurgence of the disease, without imposing any change in the underlying disease Downloaded 12/12/14 to 71.205.60.120. Redistribution subject to SIAM license or copyright; see http://www.siam.org/journals/ojsa.php and vaccine dynamics. One way that we plan to test this hypothesis is to fit the parameters of a stochastic imperfect vaccine model to pertussis data using maximum likelihood estimation as in the studies by Blackwood et al. [3] and Lavine et al. [10] .
To our knowledge the age-structured PDE system given in Definition 4.1 has not been analyzed before. A paper by Arino et al. [2] considers an integro-differential equation model of the different types of vaccine failure (with a general waning function) derived from an age-structured system. In that paper the authors focused on the system without age-structure and did not explore the effects of the vaccine failure parameters on the age distributions of the infected class.
In this study we did not examine the role of seasonality in transmission rates. We also used exponentially distributed waiting times (transfer times between components) for simplicity. This can be improved by dividing each relevant model component into multiple compartments. For example, the I class could be split up into a sequence of
compartments, and this would result in a gamma-distributed infective period with shape parameter of n [12] . This will be more important later on when we start fitting our model to data. The infective period is generally expected to have less dispersion than described by an exponential distribution. On the other hand, estimates of the waning time of vaccine-derived immunity appear to have more variation than the infective period so an exponential distribution may already be a fair approximation for this. There are studies that have introduced a continuity of vaccine states to allow for more general distribution of the waning period as well as a continuum of vaccine failure parameters [2, 4] . Transient dynamics such as the honeymoon period and outbreaks after the start of vaccination (illustrated in Figure 3 ) can be affected by the distribution of the waning period. Heffernan and Keeling [7] demonstrated that an susceptibleexposed-infected-recovered model with waning, boosting of immunity, and multiple disease compartments may generate sustained cycles of disease outbreaks. They noted that these cycles are not maintained when assuming exponential waning time. We observe this as well in the decaying magnitude of the outbreaks in Figure 3(a) .
Models of imperfect infection-derived immunity, like those of imperfect vaccines, are often formulated as waning immunity models. In this paper we focused on the population-level effects of a continuous range of vaccine types. A more general disease model would be one that allows for failure in degree, take, and duration in both infection and vaccine-derived immunity. We also did not consider the possibility that when vaccinated individuals get infected, they are less infective than they would have been without vaccination. This has been considered in the literature dealing with vaccine efficacy on infectiousness [4] . These extensions of the model and their complex effects are topics for future work.
Proof. The discriminant can be rewritten as (1 − ε W ) 2 times the following expression: 
and
Proof. It is clear that Q 0. By Proposition A.1, the discriminant satisfies 
Hence, Q Proof. The proof of this proposition is similar to the proof of local stability in Arino et al. [1] . Consider the system (2.2) in terms of three independent variables (V, S, I). The Jacobian J and its second additive component J [2] (defined in [11] ) evaluated at the endemic steady state is
Let λ 1 , λ 2 , and λ 3 be the eigenvalues of J ordered such that (λ 1 ) (λ 2 ) (λ 3 ). It is trivial to show that Tr(J) < 0 and Det(J) < 0. This allows for four possibilities:
1. (λ 1 , λ 2 , λ 3 ) ∈ R 3 and λ 1 λ 2 λ 3 < 0. 2. (λ 1 , λ 2 , λ 3 ) ∈ R 3 , λ 1 < 0 < λ 2 λ 3 , λ 1 + λ 2 < 0, and λ 1 + λ 3 < 0. 3. λ 1 ∈ R and λ 3 =λ 2 ∈ C with λ 1 < 0 and (λ 2 ) < 0. 4. λ 1 ∈ R and λ 3 =λ 2 ∈ C with λ 1 < −2 (λ 2 ) and (λ 2 ) 0. The eigenvalues of J [2] are λ i + λ j , 1 i < j 3, thus Det(J [2] ) = (λ 1 + λ 2 )(λ 1 + λ 3 )(λ 2 + λ 3 ). It is also possible to show that if R p > 1, then Det(J [2] ) < 0 (proof omitted). Since this inequality cannot hold in cases 2 and 4, only cases 1 and 3 are allowed. Thus (λ i ) < 0 for i = 1, 2, 3. This proves that the endemic equilibrium is locally asymptotically stable.
ERRATUM
The author of this paper notified SIAM of an error after publication. The legends in the lower panels of Figure 3 have been corrected. The new version of the figure follows. 
